{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:13:15Z","timestamp":1774311195640,"version":"3.50.1"},"reference-count":12,"publisher":"American Association of Psychiatric Pharmacists (AAPP)","issue":"4","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.9740\/mhc.2024.08.233","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T00:01:13Z","timestamp":1722556873000},"page":"233-235","source":"Crossref","is-referenced-by-count":2,"title":["Extrapyramidal side effects with nonantipsychotic medications"],"prefix":"10.9740","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-4228","authenticated-orcid":true,"given":"Jessa","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3880-9952","authenticated-orcid":true,"given":"Meljorie","family":"Launio","sequence":"additional","affiliation":[{"name":"Attending Psychiatrist, Loma Linda University Health, Loma Linda, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-414X","authenticated-orcid":true,"given":"Andrew M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Supervising Clinical Pharmacist, Behavioral Health Pharmacy Services, Riverside University Health System, Riverside, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4719","reference":[{"key":"i2168-9709-14-4-233-b01","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association.","year":"2022","unstructured":"American Psychiatric Association.\n          \n          \n            Diagnostic and Statistical Manual of Mental Disorders\n          . 5th ed.American Psychiatric Association; 2022."},{"key":"i2168-9709-14-4-233-b02","series-title":"Parkinsonism Relat Disord","first-page":"60","article-title":"Movement disorders induced by psychiatric drugs that do not block dopamine receptors","volume":"79","author":"Friedman","year":"2020","unstructured":"Friedman\n              JH.\n            \n          \n          Movement disorders induced by psychiatric drugs that do not block dopamine receptors. Parkinsonism Relat Disord. 2020;79:60-4. DOI: 10.1016\/j.parkreldis.2020.08.031"},{"key":"i2168-9709-14-4-233-b03","series-title":"J Affect Disord","first-page":"205","article-title":"A case of dose-dependent lithium-induced tardive dyskinesia","volume":"299","author":"Akkus","year":"2022","unstructured":"Akkus\n              M.\n            \n          \n          A case of dose-dependent lithium-induced tardive dyskinesia. J Affect Disord. 2022;299:205-6. DOI: 10.1016\/j.jad.2021.12.003"},{"key":"i2168-9709-14-4-233-b04","series-title":"J Affect Disord","first-page":"78","article-title":"Lithium monotherapy-induced tardive dyskinesia","volume":"244","author":"Fountoulakis","year":"2019","unstructured":"Fountoulakis\n              KN,\n            \n            \n              Tegos\n              T,\n            \n            \n              Kimiskidis\n              V.\n            \n          \n          Lithium monotherapy-induced tardive dyskinesia. J Affect Disord. 2019;244:78-9. DOI: 10.1016\/j.jad.2018.10.094"},{"key":"i2168-9709-14-4-233-b05","series-title":"JNNP","first-page":"181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","unstructured":"Hughes\n              AJ,\n            \n            \n              Daniel\n              SE,\n            \n            \n              Kilford\n              L,\n            \n            \n              Lees\n              AJ.\n            \n          \n          Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: A clinico-pathological study of 100 cases. JNNP1992;55:181-4. DOI: 10.1136\/jnnp.55.3.181"},{"key":"i2168-9709-14-4-233-b06","series-title":"J Neurol Sci","first-page":"120192","article-title":"Drug-induced tremor, clinical features, diagnostic approach and management","volume":"435","author":"Baizabal-Carvallo","year":"2022","unstructured":"Baizabal-Carvallo\n              JF,\n            \n            \n              Morgan\n              JC.\n            \n          \n          Drug-induced tremor, clinical features, diagnostic approach and management. J Neurol Sci. 2022;435:120192. DOI: 10.1016\/j.jns.2022.120192"},{"issue":"4","key":"i2168-9709-14-4-233-b07","series-title":"Am J Geriatr Psychiatry","first-page":"301","article-title":"Lithium use in older adults is associated with increased prescribing of parkinson medications","volume":"24","author":"Marras","year":"2016","unstructured":"Marras\n              C,\n            \n            \n              Herrmann\n              N,\n            \n            \n              Fischer\n              HD,\n            \n            \n              Fung\n              K,\n            \n            \n              Gruneir\n              A,\n            \n            \n              Rochon\n              PA,\n            \n            et al.\n          Lithium use in older adults is associated with increased prescribing of parkinson medications. Am J Geriatr Psychiatry. 2016;24(4):301-9. DOI: 10.1016\/j.jagp.2015.11.004"},{"issue":"2","key":"i2168-9709-14-4-233-b08","series-title":"J Am Pharm Assoc (2003","first-page":"e28-36","article-title":"Selective serotonin reuptake inhibitor-induced akathisia","volume":"49","author":"Koliscak","year":"2009","unstructured":"Koliscak\n              LP,\n            \n            \n              Makela\n              EH.\n            \n          \n          Selective serotonin reuptake inhibitor-induced akathisia. J Am Pharm Assoc (2003). 2009;49(2):e28-36; quiz e37-8. DOI: 10.1331\/JAPhA.2009.08083"},{"key":"i2168-9709-14-4-233-b09","series-title":"British Journal Psychiatry","first-page":"672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","unstructured":"Barnes\n              TR.\n            \n          \n          A rating scale for drug-induced akathisia. British Journal Psychiatry. 1989;154:672-6.10.1192\/bjp.154.5.672"},{"key":"i2168-9709-14-4-233-b10","series-title":"Acta Psychiatrica Scandinavia","first-page":"11","article-title":"A rating scale for extrapyramidal side effects","volume":"45","author":"Simpson","year":"1970","unstructured":"Simpson\n              GM,\n            \n            \n              Angus\n              JW.\n            \n          \n          A rating scale for extrapyramidal side effects. Acta Psychiatrica Scandinavia. 1970;45:11-9. DOI: 10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"i2168-9709-14-4-233-b11","series-title":"Psychiatric Services","first-page":"1172","article-title":"How to examine patients using the abnormal involuntary movement scale","volume":"39","author":"Munetz","year":"1988","unstructured":"Munetz\n              MR,\n            \n            \n              Benjamin\n              S.\n            \n          \n          How to examine patients using the abnormal involuntary movement scale. Psychiatric Services. 1988;39:1172-7. DOI: 10.1176\/ps.39.11.1172"},{"issue":"2-3","key":"i2168-9709-14-4-233-b12","series-title":"Schizophr Res","first-page":"247","article-title":"Manual for the Extrapyramidal Symptom Rating Scale (ESRS)","volume":"76","author":"Chouinard","year":"2005","unstructured":"Chouinard\n              G,\n            \n            \n              Margolese\n              HC.\n            \n          \n          Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res. 2005;76(2-3):247-65. Erratum in: Schizophr Res. 2006;85(1-3):305.DOI: 10.1016\/j.schres.2005.02.0131"}],"container-title":["Mental Health Clinician"],"original-title":[],"link":[{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/14\/4\/article-p233.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/meridian.allenpress.com\/mhc\/article-pdf\/14\/4\/233\/3411186\/i2168-9709-14-4-233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/14\/4\/article-p233.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/mhc.kglmeridian.com\/downloadpdf\/journals\/mhcl\/14\/4\/article-p233.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T00:01:56Z","timestamp":1740268916000},"score":1,"resource":{"primary":{"URL":"https:\/\/mhc.kglmeridian.com\/view\/journals\/mhcl\/14\/4\/article-p233.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":12,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.9740\/mhc.2024.08.233","relation":{},"ISSN":["2168-9709"],"issn-type":[{"value":"2168-9709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]}}}